Blog

Antibody formulation is essential for stability and delivery. Biointron provides strategies to design effective preparations for clinical use.

Learn how fully human and humanized mAbs differ in generation, immunogenicity, and function—plus ADA risks and engineering options. Explore Biointron’s platforms.

Manufacturing optimization ensures quality and scale. Biointron details strategies to streamline antibody production and meet therapeutic demands.

ADCs have evolved into powerful cancer drugs. Biointron reviews their history, design improvements, and future directions in targeted therapy.

Immuno-oncology leverages immune checkpoints as targets. Biointron highlights antibodies advancing cancer therapy by modulating immune pathways.

Learn what antibody-based diagnostics are, including ELISA, Western blot, IHC, and rapid tests. Discover applications in HIV, COVID-19, cancer, and more.

AbDrop™ isolates diverse, high-affinity antibodies rapidly. Biointron shows how this platform transforms discovery with speed, scale, and precision.

DAR is key to ADC success. Biointron explains how drug-to-antibody ratios shape potency, safety, and outcomes in cancer therapy.

Antibody biomarkers guide precision medicine. Biointron explores how biomarkers support ADC therapies, patient selection, and clinical decision-making.

Antibody production relies on diverse technologies. Biointron reviews methods from hybridoma to recombinant platforms that power research and drug development.

Pharmacokinetics defines antibody behavior in the body. Biointron explains ADME principles and their role in designing effective antibody drugs.

Antibody stability is critical for therapeutics. Biointron outlines factors that affect stability and solutions to maintain quality through development.